FDA Submits Proposed Collection of Information for Review Under Paperwork Reduction Act

Summary

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance, as required by the Paperwork Reduction Act of 1995, concerning records and reports on approved new animal drugs and adverse event reports on FDA forms 1932, 1932a, and 2301.